Alzheimer's drug shows promise in early results of study

In this image from video provided by Washington University, a p-tau217 test for Alzheimer's disease is seen at a laboratory in St. Louis, Mo., on July 27, 2020.  (Huy Mach/University of Washington via AP) In this image from video provided by Washington University, a p-tau217 test for Alzheimer's disease is seen at a laboratory in St. Louis, Mo., on July 27, 2020. (Huy Mach/University of Washington via AP)

COVID-19 COVERAGE

Coronavirus in Canada

Track COVID-19 cases, hospitalizations and wastewater numbers across Canada

Coronavirus in Canada COVID-19 cases charted across Canada

How U.S. states are doing

How do Canadian provinces and territories compare to American states?

Canada and other nations

Curious how different countries are faring? Chart and compare the curves using our interactive graphs

The COVID-19 Brief

Sign up to receive the most important updates in your inbox two times a week

This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2, orange, emerging from the surface of cells, green, cultured in the lab. (NIAID-RML via AP) This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2, orange, emerging from the surface of cells, green, cultured in the lab. (NIAID-RML via AP)

CTVNews.ca Top Stories

Impeachment talk at Trump Org. trial: Did witness misspeak?

There was talk of impeachment Monday at the Trump Organization's criminal tax fraud trial -- not former President Donald Trump's, which happened twice -- but whether lawyers for his company were angling to impeach their own witness, longtime Trump accountant Donald Bender.

STAY CONNECTED